Review
Accepted on 16 May 2024
Immunotherapy in Melanoma: advances, pitfalls, and future perspectives
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1403021
Type at least 3 characters
1,703 articles
Articles
Review
Accepted on 16 May 2024
Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Skeletal Diseases
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1268019
Correction
Published on 16 May 2024
Corrigendum: Mechanotransductive receptor Piezo1 as a promising target in the treatment of fibrosis diseases
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1420585
Review
Accepted on 15 May 2024
Signaling Pathways Activated and Regulated by Stem Cell-Derived Exosome Therapy
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1407148
Original Research
Accepted on 15 May 2024
ACSS2 Enables Melanoma Cell Survival and Tumor Metastasis by Negatively Regulating the Hippo Pathway
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1423795
Original Research
Published on 15 May 2024
MicroRNA as a promising molecular biomarker in the diagnosis of breast cancer
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1337706
- 135 views
Review
Published on 14 May 2024
Circulating microRNAs as promising diagnostic biomarkers for hepatocellular carcinoma: a systematic review and meta-analysis
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1353547
- 157 views
Policy Brief
Accepted on 13 May 2024
Patient Safety and Health Care Quality of U.S. Laboratory Developed Tests (LDTs) in the AI/ML era of Precision Medicine
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1407513
Original Research
Accepted on 13 May 2024
A Deep Learning method for classification of HNSCC and HPV patients using single-cell transcriptomics
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1395721
Original Research
Accepted on 10 May 2024
Longitudinal evaluation of laboratory results and method precision in worldwide erythropoietin external quality assessments
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1390079
Original Research
Accepted on 09 May 2024
Mechanisms underlying the therapeutic effects of Semen Cuscutae in treating Recurrent Spontaneous Abortion based on Network Pharmacology and Molecular Docking
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1282100
Review
Published on 09 May 2024
Next generation single-domain antibodies against respiratory zoonotic RNA viruses
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1389548
- 253 views
Editorial
Accepted on 08 May 2024
Editorial on the Research Topic: "Molecular Mechanisms Underlying Polycystic Kidney Disease: From the Smallest Bricks to the Big Scenario".
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1429206
Editorial
Accepted on 07 May 2024
Editorial -Molecular Mechanisms of Cilia Related Diseases
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1421419
Original Research
Published on 07 May 2024
Multikinase inhibitors modulate non-constitutive proteasome expression in colorectal cancer cells
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1351641
- 342 views
Original Research
Accepted on 06 May 2024
STAT3 drives the malignant progression of low-grade gliomas through modulating the expression of STAT1, FOXO1, and MYC
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2024.1419072